Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The preferences of potential stakeholders in psychiatric genomic research regarding consent procedures and information delivery

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Birth dimensions, severe mental illness and risk of type 2 diabetes in a cohort of Danish men born in 1953

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Association between prior somatic disease and 5-year relapse risk among 11,856 incident patients with schizophrenia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Healthy minds 0-100 years: Optimising the use of European brain imaging cohorts ("Lifebrain")

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Plasma Cotinine Cutoff for Distinguishing Smokers From Nonsmokers Among Persons Living With HIV

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  2. Characterization of Familial and Sporadic Migraine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Life events and donor lapse among blood donors in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Genomic sequencing plays an increasing role in genetic research, also in psychiatry. This raises challenges concerning the validity and type of the informed consent and the return of incidental findings. However, no solution currently exists on the best way to obtain the informed consent and deliver findings to research subjects.

AIMS: This study aims to explore the attitudes among potential stakeholders in psychiatric genomic research toward the consenting procedure and the delivery of incidental findings.

METHODS: We developed a cross-sectional web-based survey among five groups of stakeholders. A total of 2637 stakeholders responded: 241 persons with a mental disorder, 671 relatives, 1623 blood donors, 74 psychiatrists, and 28 clinical geneticists.

RESULTS: The stakeholders wanted active involvement as 92.7% preferred a specific consent and 85.1% wanted to receive information through a dynamic consent procedure. The majority of stakeholders preferred to receive genomic information related to serious or life-threatening health conditions through direct contact (69.5%) with a health professional, i.e. face-to-face consultation or telephone consultation (82.4%). Persons with mental disorders and relatives did not differ in their attitudes from the other stakeholder groups.

CONCLUSION: The findings illustrate that the stakeholders want to be more actively involved and consider consent as a reciprocal transaction between the involved subjects and the researchers in the project. The results highlight the importance of collaboration between researchers and clinical geneticists as the latter are trained, through their education and clinical experience, to return and explain genomic data to patients, relatives, and research subjects.

OriginalsprogEngelsk
TidsskriftEuropean psychiatry : the journal of the Association of European Psychiatrists
Vol/bind55
Sider (fra-til)29-35
Antal sider7
ISSN0924-9338
DOI
StatusUdgivet - 2019

ID: 55553711